GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Ablynx NV (XBRU:ABLXS) » Definitions » Inventory-to-Revenue

Ablynx NV (XBRU:ABLXS) Inventory-to-Revenue : 0.00 (As of Dec. 2017)


View and export this data going back to . Start your Free Trial

What is Ablynx NV Inventory-to-Revenue?

Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue. Ablynx NV's Average Total Inventories for the quarter that ended in Dec. 2017 was €0.00 Mil. Ablynx NV's Revenue for the six months ended in Dec. 2017 was €20.90 Mil. Ablynx NV's Inventory-to-Revenue for the quarter that ended in Dec. 2017 was 0.00.

Ablynx NV's Inventory-to-Revenue for the quarter that ended in Dec. 2017 stayed the same from Jun. 2017 (0.00) to Jun. 2017 (0.00)

Days Inventory indicates the number of days of goods in sales that a company has in the inventory.

Inventory Turnover measures how fast the company turns over its inventory within a year.


Ablynx NV Inventory-to-Revenue Historical Data

The historical data trend for Ablynx NV's Inventory-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Ablynx NV Inventory-to-Revenue Chart

Ablynx NV Annual Data
Trend Dec08 Dec09 Dec10 Dec11 Dec12 Dec13 Dec14 Dec15 Dec16 Dec17
Inventory-to-Revenue
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

Ablynx NV Semi-Annual Data
Dec07 Dec08 Jun09 Dec09 Jun10 Dec10 Jun11 Dec11 Jun12 Dec12 Jun13 Dec13 Jun14 Dec14 Jun15 Dec15 Jun16 Dec16 Jun17 Dec17
Inventory-to-Revenue Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of Ablynx NV's Inventory-to-Revenue

For the Biotechnology subindustry, Ablynx NV's Inventory-to-Revenue, along with its competitors' market caps and Inventory-to-Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Ablynx NV's Inventory-to-Revenue Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Ablynx NV's Inventory-to-Revenue distribution charts can be found below:

* The bar in red indicates where Ablynx NV's Inventory-to-Revenue falls into.



Ablynx NV Inventory-to-Revenue Calculation

Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.

Ablynx NV's Inventory-to-Revenue for the fiscal year that ended in Dec. 2017 is calculated as

Inventory-to-Revenue (A: Dec. 2017 )
=Average Total Inventories / Revenue
=( (Total Inventories (A: Dec. 2016 ) + Total Inventories (A: Dec. 2017 )) / count ) / Revenue (A: Dec. 2017 )
=( (0 + 0) / 1 ) / 55.562
=0 / 55.562
=0.00

Ablynx NV's Inventory-to-Revenue for the quarter that ended in Dec. 2017 is calculated as

Inventory-to-Revenue (Q: Dec. 2017 )
=Average Total Inventories / Revenue
=( (Total Inventories (Q: Jun. 2017 ) + Total Inventories (Q: Dec. 2017 )) / count ) / Revenue (Q: Dec. 2017 )
=( (0 + 0) / 1 ) / 20.897
=0 / 20.897
=0.00

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Ablynx NV  (XBRU:ABLXS) Inventory-to-Revenue Explanation

An increase in Inventory-to-Revenue from one quarter to the next indicates that one of the following is happening:

1. investment in inventory is growing more rapidly than revenue
2. revenue are dropping
No matter which situation is causing the problem, an increase in the Inventory-to-Revenue may signal an oncoming cash flow problem.

Likewise, a decrease in the Inventory-to-Revenue from one quarter to next indicates that one of these is occurring:

1. investment in inventory is shrinking in relation to revenue
2. revenue are increasing
No matter which situation is causing the reduction in the Inventory-to-Revenue, either one suggests that business's inventory levels and its cash flow are effectively managed.

More Related Terms:

1. Days Inventory indicates the number of days of goods in sales that a company has in the inventory.

Ablynx NV's Days Inventory for the six months ended in Dec. 2017 is calculated as:

Days Inventory=Average Total Inventories (Q: Dec. 2017 )/Cost of Goods Sold (Q: Dec. 2017 )*Days in Period
=0/0*365 / 2
=

2. Inventory Turnover measures how fast the company turns over its inventory within a year.

Ablynx NV's Inventory Turnover for the quarter that ended in Dec. 2017 is calculated as

Inventory Turnover=Cost of Goods Sold (Q: Dec. 2017 ) / Average Total Inventories (Q: Dec. 2017 )
=0 / 0
=

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Ablynx NV Inventory-to-Revenue Related Terms

Thank you for viewing the detailed overview of Ablynx NV's Inventory-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.


Ablynx NV (XBRU:ABLXS) Business Description

Traded in Other Exchanges
N/A
Address
Ablynx NV is a biopharmaceutical company engaged in the development of Nanobodies, proprietary therapeutic proteins based on single-domain antibody fragments. It has 45 proprietary and partnered programs in development in various therapeutic areas including inflammation, hematology, immuno-oncology, oncology and respiratory disease. It has collaborations with multiple pharmaceutical companies including AbbVie; Boehringer Ingelheim; Eddingpharm; Merck & Co., Inc., Kenilworth, New Jersey, USA; Merck KGaA; Novartis; Novo Nordisk; Sanofi and Taisho Pharmaceuticals. The company generates revenue from research collaboration agreements and from government grants.

Ablynx NV (XBRU:ABLXS) Headlines

No Headlines